Question to the Cabinet Office:

To ask His Majesty's Government what consideration they have given to introducing a tax on companies which benefited from (1) the research conducted on British infected blood victims, and (2) the drugs used to treat infected blood patients; and what assessment they have made of the benefits and risks of taxing those companies.

The Infected Blood Inquiry recommended that a compensation scheme be set up as soon as possible, and by centrally funding the scheme, the Government has been able quickly allocate the money necessary.

The Government firmly believes that access to redress is fundamental in upholding justice and fairness in our society. People must have avenues to seek recourse when they have been wronged or harmed. We hope the Infected Blood Compensation Scheme provides some closure to those who have been wronged under some of those most devastating circumstances.